{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-102903","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2024-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.975897+00:00","generated_at":"2026-05-29T18:05:11.531703+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Pasithea enters $2.08M ATM equity facility with H.C. Wainwright","bullets":["ATM agreement with H.C. Wainwright for up to $2,076,000 in common stock sales.","Sales agent commission: 3% of gross proceeds; company reimburses up to $100k in legal fees.","No minimum obligation; company may suspend or terminate the offering at any time.","Sales will be made on Nasdaq as 'at the market' offerings per Rule 415."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-102903","json":"https://secwatch.observer/filing/0001213900-24-102903.json","markdown":"https://secwatch.observer/filing/0001213900-24-102903.md","text":"https://secwatch.observer/filing/0001213900-24-102903.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390024102903/0001213900-24-102903-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390024102903/ea0222547-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T18:05:11.531703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}